# Lexaria Bioscience Corp. (LEXX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$12M |
| 2024 | -$6M |
| 2023 | -$7M |
| 2022 | -$7M |
| 2021 | -$6M |
| 2016 | -$1M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-02-28 | -$1M |
| 2025-11-30 | -$2M |
| 2025-05-31 | -$4M |
| 2025-02-28 | -$3M |
| 2024-11-30 | -$3M |
| 2024-05-31 | -$2M |
| 2024-02-29 | -$668,005 |
| 2023-11-30 | -$1M |
| 2023-05-31 | -$2M |
| 2023-02-28 | -$1M |
| 2022-11-30 | -$2M |
| 2022-05-31 | -$2M |
| 2021-05-31 | -$3M |
| 2017-11-30 | -$578,713 |
| 2016-11-30 | -$400,553 |
| 2016-05-31 | -$264,201 |
| 2016-02-29 | -$274,557 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/LEXX/operating-income)